4//SEC Filing
Boudreau Philip P 4
Accession 0001415889-25-005885
CIK 0000001800other
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 5:46 PM ET
Size
8.3 KB
Accession
0001415889-25-005885
Insider Transaction Report
Form 4
Boudreau Philip P
EXECUTIVE VICE PRESIDENT
Transactions
- Award
Common shares without par value
2025-02-25+22,495→ 61,461 total - Award
Option (right to buy)
2025-02-25+83,783→ 83,783 totalExercise: $135.42From: 2026-02-25Exp: 2035-02-24→ Common Shares (83,783 underlying)
Holdings
- 360(indirect: By Trust)
Common shares without par value
Footnotes (3)
- [F1]These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes.
- [F2]Balance in the Abbott Laboratories Stock Retirement Trust as of February 25, 2025.
- [F3]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 27,927 on February 25, 2026, 27,928 on February 25, 2027, and 27,928 on February 25, 2028.
Documents
Issuer
ABBOTT LABORATORIES
CIK 0000001800
Entity typeother
Related Parties
1- filerCIK 0001805099
Filing Metadata
- Form type
- 4
- Filed
- Feb 26, 7:00 PM ET
- Accepted
- Feb 27, 5:46 PM ET
- Size
- 8.3 KB